References
Grützmann R, Niedergethmann M, Pilarsky C, Klöppel G, Saeger HD. Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment. Oncologist. 2010;15(12):1294–309.
Fong ZV, Fernández-Del Castillo C. Intraductal papillary mucinous neoplasm of the pancreas. Surg Clin North Am. 2016;96(6):1431–45.
Winter JM, Cameron JL, Lillemoe KD, Campbell KA, Chang D, Riall TS, et al. Periampullary and pancreatic incidentaloma: a single institution’s experience with an increasingly common diagnosis. Ann Surg. 2006;243(5):673–80.
Valsangkar NP, Morales-Oyarvide V, Thayer SP, Ferrone CR, Wargo JA, Warshaw AL, et al. 851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital. Surgery. 2012;152(3 Suppl 1):S4–12.
Buscarini E, Pezzilli R, Cannizzaro R, De Angelis C, Gion M, Morana G, et al. Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis. 2014;46(6):479–93.
DiMaio CJ. Current guideline controversies in the management of pancreatic cystic neoplasms. Gastrointest Endosc Clin N Am. 2018;28(4):529–47.
European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018;67(5):789–804.
Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12(3):183–97.
Wang W, Zhang L, Chen L, Wei J, Sun Q, Xie Q, et al. Serum carcinoembryonic antigen and carbohydrate antigen 19-9 for prediction of malignancy and invasiveness in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Biomed Rep. 2015;3(1):43–50.
Stauffer JA, Nguyen JH, Heckman MG, Grewal MS, Dougherty M, Gill KR, et al. Patient outcomes after total pancreatectomy: a single centre contemporary experience. HPB (Oxford). 2009;11(6):483–92.
Farnell MB. Surgical management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas. J Gastrointest Surg. 2008;12(3):414–6.
Marchegiani G, Andrianello S, Perri G, Bonamini D, De Robertis R, Malleo G, et al. Vanishing pancreatic cysts during follow-up: another step towards de-emphasizing cyst size as a major clinical predictor of malignancy. Dig Surg. 2018;35(6):508–13.
Rossi RE, Massironi S. Intraductal papillary mucinous neoplasms of the pancreas: a clinical challenge. Expert Rev Gastroenterol Hepatol. 2018;12(11):1123–33.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Ethical Approval
All procedures performed in the study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent
Written informed consent from the patient’s next of kin was obtained for publication of the case details.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pandit, N., Yadav, T.N., Lacoul, R. et al. Invasive Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas Causing Duodenal Infiltration and Obstruction: a Case Report. J Gastrointest Canc 51, 292–295 (2020). https://doi.org/10.1007/s12029-019-00225-w
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-019-00225-w